⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL148541 | 1.00 | — | — | |
| Methoxymethane SCHEMBL1408959 | 1.00 | — | — | |
| Methoxymethane SCHEMBL1999404 | 1.00 | — | — | |
| Methoxymethane SCHEMBL16443626 | 1.00 | — | — | |
| Methoxymethane SCHEMBL3290081 | 1.00 | — | — | |
| Methoxymethane SCHEMBL19128498 | 0.87 | — | — | |
| Methoxymethane SCHEMBL12190176 | 0.82 | — | — | |
| Methoxymethane SCHEMBL5707121 | 0.82 | — | — | |
| Methoxymethane SCHEMBL16998540 | 0.82 | — | — | |
| Methoxymethane SCHEMBL868 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1613343-B1 | INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | BIOCON LTD (IN) | 2016-12-07 | — | — | EP | disclosed |
| US-7611864-B2 | Proinsulin polypeptide-oligomer conjugates | BIOCON LIMITED (IN) | 2009-11-03 | — | — | US | disclosed |
| EP-1430082-B1 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | BIOCON LTD (IN) | 2009-10-28 | — | — | EP | disclosed |
| US-7368260-B2 | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | BIOCON LIMITED (IN) | 2008-05-06 | — | — | US | disclosed |
| EP-1613343-A4 | INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | BIOCON LTD (IN) | 2008-03-05 | — | — | EP | disclosed |
| US-7312192-B2 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | BIOCON LIMITED (IN) | 2007-12-25 | — | — | US | disclosed |
| US-7196059-B2 | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | BIOCON LIMITED (IN) | 2007-03-27 | — | — | US | disclosed |
| US-7166571-B2 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | BIOCON LIMITED (IN) | 2007-01-23 | — | — | US | disclosed |
| US-7030082-B2 | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith | NOBEX CORPORATION (US) | 2006-04-18 | — | — | US | disclosed |
| EP-1613343-A2 | INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | Nobex Corporation (US) | 2006-01-11 | — | — | EP | disclosed |
| US-20040038866-A1 | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | BIOCON LIMITED (IN) | 2004-02-26 | — | — | US | disclosed |
| US-20040017387-A1 | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith | BIOCON LIMITED (IN) | 2004-01-29 | — | — | US | disclosed |
| US-20030229009-A1 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | BIOCON LIMITED (IN) | 2003-12-11 | — | — | US | disclosed |
| US-20030228652-A1 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | NOBEX CORPORATION | 2003-12-11 | — | — | US | disclosed |
| US-20030087808-A1 | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | BIOCON LIMITED (IN) | 2003-05-08 | — | — | US | disclosed |
| US-20030083232-A1 | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | BIOCON LIMITED (IN) | 2003-05-01 | — | — | US | disclosed |
| US-20030069170-A1 | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | BIOCON LIMITED (IN) | 2003-04-10 | — | — | US | disclosed |
| WO-2003022210-A2 | PHARMACEUTICAL COMPOSITIONS OF DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022996-A2 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022208-A2 | PHARMACEUTICAL COMPOSITIONS OF INSULIN DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |